Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Catch up on the latest in GU cancers from leading experts at ASCO GU 2023. In prostate cancer, PARP inhibitors were a hot topic of discussion, with data from TALAPRO-2 (NCT03395197) and TRITON3 (NCT02975934) being presented. In bladder cancer, IMvigor130 (NCT02807636) and TROPHY-U-01 (NCT03547973) were two of the key trials, with additional discussions on antibody-drug conjugates (ADCs), nectin-4-targeted therapies, and the use of molecular profiling in clinical practice. Finally, in kidney cancer, there were updates from ZIRCON (NCT03849118), COSMIC-313 (NCT03937219), and CheckMate 9ER (NCT03141177).
View all videos

GU Cancers 2023

ASCO Genitourinary Cancers Symposium 2023
16–18 February 2023 | San Francisco, CA

May is #SkinCancer Awareness Month πŸ“£

Check out our NEW podcast episode: Updates in #immunotherapy for #skincancer 🎧

With leading experts @OmidHamidMD @PAscierto @ProfGLongMIA & Karijn Suijkerbuijk

πŸ‘‰ https://www.vjoncology.com/podcast/updates-in-immunotherapy-for-skin-cancer/

Join us for our Post-ASCO 2024 #GUCancer Highlights πŸ“£

🌟 Chaired by @tompowles1

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agenda available soon πŸ“

REGISTER πŸ‘‰ https://us06web.zoom.us/webinar/register/7117150941646/WN_hac72vpiRrGPmJzcOCMeIw

#ASCO24

Join us for our Post-ASCO 2024 Highlights πŸ“£

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agendas available soon πŸ“

REGISTER πŸ‘‰ https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

Missed out on #ESMOBreast24 last week?

http://VJOncology.com has the key updates, brought to you by the experts themselves - ready to watch whenever you are! πŸ‘€

@β€ŒmyESMO #bcsm #breastcancer

Join us for our Post-ASCO 2024 #LungCancer Highlights πŸ“£

🌟 Chaired by Professor Sanjay Popat

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agenda available soon πŸ“

REGISTER πŸ‘‰ https://us06web.zoom.us/webinar/register/4117150940818/WN_77bU3HolRNS0T0MkOrJQOA

#ASCO24

Load More

GU Cancers 2023

ASCO Genitourinary Cancers Symposium 2023
16–18 February 2023 | San Francisco, CA
Catch up on the latest in GU cancers from leading experts at ASCO GU 2023. In prostate cancer, PARP inhibitors were a hot topic of discussion, with data from TALAPRO-2 (NCT03395197) and TRITON3 (NCT02975934) being presented. In bladder cancer, IMvigor130 (NCT02807636) and TROPHY-U-01 (NCT03547973) were two of the key trials, with additional discussions on antibody-drug conjugates (ADCs), nectin-4-targeted therapies, and the use of molecular profiling in clinical practice. Finally, in kidney cancer, there were updates from ZIRCON (NCT03849118), COSMIC-313 (NCT03937219), and CheckMate 9ER (NCT03141177).
View all videos

May is #SkinCancer Awareness Month πŸ“£

Check out our NEW podcast episode: Updates in #immunotherapy for #skincancer 🎧

With leading experts @OmidHamidMD @PAscierto @ProfGLongMIA & Karijn Suijkerbuijk

πŸ‘‰ https://www.vjoncology.com/podcast/updates-in-immunotherapy-for-skin-cancer/

Join us for our Post-ASCO 2024 #GUCancer Highlights πŸ“£

🌟 Chaired by @tompowles1

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agenda available soon πŸ“

REGISTER πŸ‘‰ https://us06web.zoom.us/webinar/register/7117150941646/WN_hac72vpiRrGPmJzcOCMeIw

#ASCO24

Join us for our Post-ASCO 2024 Highlights πŸ“£

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agendas available soon πŸ“

REGISTER πŸ‘‰ https://www.vjoncology.com/feature/post-asco-2024-highlights/

#ASCO24 @DrSanjayPopat @tompowles1 @stolaney1 @LizzySmyth1

Missed out on #ESMOBreast24 last week?

http://VJOncology.com has the key updates, brought to you by the experts themselves - ready to watch whenever you are! πŸ‘€

@β€ŒmyESMO #bcsm #breastcancer

Join us for our Post-ASCO 2024 #LungCancer Highlights πŸ“£

🌟 Chaired by Professor Sanjay Popat

Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 πŸ”¦

Agenda available soon πŸ“

REGISTER πŸ‘‰ https://us06web.zoom.us/webinar/register/4117150940818/WN_77bU3HolRNS0T0MkOrJQOA

#ASCO24

Load More